Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycogen synthase kinase 3 beta | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | thymidylate synthase | 0.0124 | 0.3463 | 0.349 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0124 | 0.3463 | 0.3423 |
Giardia lamblia | Kinase, CMGC GSK | 0.0058 | 0.0049 | 0.5 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0251 | 1 | 1 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.0169 | 0.5798 | 0.5777 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.0169 | 0.5798 | 0.5822 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0251 | 1 | 1 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0249 | 0.9923 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0249 | 0.9923 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0251 | 1 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0058 | 0.0049 | 0.005 |
Brugia malayi | Dihydrofolate reductase | 0.0249 | 0.9923 | 1 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0066 | 0.0467 | 1 |
Brugia malayi | Zinc finger, C2H2 type family protein | 0.0066 | 0.0467 | 0.047 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0066 | 0.0467 | 0.0423 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.0169 | 0.5798 | 0.3614 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.0169 | 0.5798 | 0.5777 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0066 | 0.0467 | 0.0419 |
Onchocerca volvulus | 0.0124 | 0.3463 | 1 | |
Echinococcus granulosus | dihydrofolate reductase | 0.0249 | 0.9923 | 1 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0249 | 0.9923 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0066 | 0.0467 | 1 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0249 | 0.9923 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0066 | 0.0467 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0124 | 0.3463 | 0.3458 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0066 | 0.0467 | 0.0423 |
Brugia malayi | intracellular kinase | 0.0058 | 0.0049 | 0.005 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0249 | 0.9923 | 1 |
Brugia malayi | hypothetical protein | 0.0059 | 0.0102 | 0.0103 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.0169 | 0.5798 | 0.5799 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0249 | 0.9923 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0066 | 0.0467 | 1 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0169 | 0.5798 | 0.5777 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0066 | 0.0467 | 0.0423 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0059 | 0.0102 | 0.1257 |
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.0169 | 0.5798 | 0.5777 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.0169 | 0.5798 | 0.5777 |
Echinococcus granulosus | thymidylate synthase | 0.0124 | 0.3463 | 0.3458 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.0169 | 0.5798 | 0.3614 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0066 | 0.0467 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0058 | 0.0049 | 0.005 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0066 | 0.0467 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0251 | 1 | 1 |
Giardia lamblia | Kinase, CMGC GSK | 0.0058 | 0.0049 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydroorotate dehydrogenase 2 | 0.0169 | 0.5798 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0169 | 0.5798 | 0.5777 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0249 | 0.9923 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.0124 | 0.3463 | 0.349 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0169 | 0.5798 | 0.5843 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0066 | 0.0467 | 1 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0169 | 0.5798 | 0.5843 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0169 | 0.5798 | 0.5777 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0251 | 1 | 1 |
Brugia malayi | dihydrofolate reductase family protein | 0.0249 | 0.9923 | 1 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0066 | 0.0467 | 0.0423 |
Leishmania major | dihydroorotate dehydrogenase | 0.0169 | 0.5798 | 0.5777 |
Echinococcus multilocularis | thymidylate synthase | 0.0124 | 0.3463 | 0.3458 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0059 | 0.0102 | 0.0053 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2613 nM | Inhibition of recombinant GSK3beta (unknown origin) | ChEMBL. | 18324764 |
IC50 (binding) | = 2613 nM | Inhibition of recombinant GSK3beta (unknown origin) | ChEMBL. | 18324764 |
IC50 (binding) | = 2613 uM | Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha | ChEMBL. | 11266159 |
IC50 (binding) | = 2613 uM | Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha | ChEMBL. | 11266159 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.